Skip to content
OpenCapital
Get started

Labcorp Holdings LH Cash & Equivalents

Cash & Equivalents at other companies

Myriad Genetics logo
Myriad GeneticsMYGN
$126M+24.8%
Azenta logo
AzentaAZTA
$125.19M—
Quest Diagnostics logo
Quest DiagnosticsDGX
$393M+109%
NeoGenomics logo
NeoGenomicsNEO
$146.14M-57.8%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$198.2M-14.5%
Exagen Inc. logo
Exagen Inc.XGN
$21.71M+90.6%

Other financials

Income statement

See full
Revenue$3.5B+5.8%
Gross profit$1.0B+6.9%
Operating income$380.8M+16.8%
Net income$277.8M+30.5%
EPS (diluted)$3.35+32.9%

Balance sheet

See full
Total debt$7.2B+11.1%
Total equity$8.7B+5.1%
Total assets$19.1B+8.4%

Cash flow

See full
Operating cash flow$191.5M+935%
CapEx$121.0M-4.0%
Free cash flow$70.5M+166%

Valuation

See full
Market cap$22.96B+9.4%
Enterprise value$29.22B+10.7%
P/E24.4×-3.1×
P/S1.6×+0.1×

Profitability

See full
Gross margin28.8%+0.9pp
Operating margin10.2%+1.9pp
Net margin6.7%+1.1pp
FCF margin9.8%+1.0pp

Returns & leverage

See full
Return on equity11.1%+2.1pp
Debt / equity0.8×0.0×
Current ratio1.7×-0.1×

Where this comes from

Reported directly by Labcorp Holdings in its filing.

Tagged under the XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue.

The official record: Labcorp Holdings’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Labcorp Holdings's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Labcorp Holdings's cash & equivalents?
Labcorp Holdings (LH) reported cash & equivalents of $981.1M in Q1 2026.
How has Labcorp Holdings's cash & equivalents changed year-over-year?
Labcorp Holdings's cash & equivalents increased by 165.6% year-over-year, from $369.4M to $981.1M.
What is the long-term trend for Labcorp Holdings's cash & equivalents?
Over 5 years (2020 to 2025), Labcorp Holdings's cash & equivalents has grown at a -16.6% compound annual growth rate (CAGR), from $1.32B to $532.3M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.